Concepedia

Kim Kraynyak

KK

Statistics

Publications

5

Citations

157

H-Index

5

Active since

2014

Affiliations

Inovio Pharmaceuticals (United States)(Current)

The Wistar Institute

University of Pennsylvania

Hospital of the University of Pennsylvania

Kim Kraynyak is an author at Inovio Pharmaceuticals (United States) specializing in immunology, immunology of infectious diseases, and infectious diseases.

Publications per year

2014–2021

5

Publications

5

Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL

Prakash Bhuyan, Michael Dallas, Kim Kraynyak et al. · Human Vaccines & Immunotherapeutics · 2020 · 52 citations · Full text

, , +17

INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants

Viviane M. Andrade, Aaron Christensen-Quick, Joseph Agnes et al. · npj Vaccines · 2021 · 50 citations · Full text

, , +17

Synthetic Consensus HIV-1 DNA Induces Potent Cellular Immune Responses and Synthesis of Granzyme B, Perforin in HIV Infected Individuals

Matthew P. Morrow, Pablo Tebas, Jian Yan et al. · Molecular Therapy · 2014 · 19 citations · Full text

, , +16

INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants

Viviane M. Andrade, Aaron Christensen-Quick, Joseph Agnes et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 19 citations · Full text

, , +17

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Casey R. Ager, Matthew J. Reilley, Courtney Nicholas et al. · Journal for ImmunoTherapy of Cancer · 2016 · 17 citations · Full text

, , +17

1–5 of 5